FINWIRES · TerminalLIVE
FINWIRES

研究快訊:CFRA維持對景順有限公司股票的買進評等。

By

-- 獨立研究機構CFRA向提供了以下研究報告。 CFRA分析師的觀點總結如下:我們將12個月目標價下修2美元至29美元,對IVZ股票的估值分別為:基於我們2027年調整後每股收益3.05美元的9.5倍,基於我們2026年每股收益2.65美元的10.9倍(今日下修0.05美元),而一年期每股收益2.65美元的平均市盈率為10.05美元),而一年期平均市盈率為100.05美元),而一年期平均市盈率為100.05美元),而一年期平均市盈率為100.05美元),而一年期平均市盈率為100.05美元),而一年期平均市盈率為100.05美元),而一年期平均市盈率為100.05美元),而一年期平均市盈率為100.05美元),而一年期平均市盈率為100.05美元),而一年期平均市盈率為100.05美元),而一年期平均市盈率為100.05美元),而一年期平均市盈率為1096倍。景順(Invesco)公佈的2026年第一季調整後每股收益為0.57美元,低於我們0.62美元的預期,但接近0.58美元的市場普遍預期。同時,該公司連續第11季實現正的內生成長,淨長期資金流入達218億美元。受QQQ轉換收益和平均資產管理規模(AUM)提升的影響,投資管理費年增25.6%至13.8億美元,但由於QQQ的結構性調整,服務費下降了18.6%。我們認為QQQ轉換正按預期推進,顯著促進了收入成長,同時也展現了IVZ從其旗艦產品中獲取更多費用收入的能力。目前該股的本益比為9.7倍(基於我們2026年的每股盈餘預期),股息殖利率為3.3%,我們認為該股被低估。

Related Articles

Research

Research Alert: CFRA Keeps Buy Opinion On Shares Of Cincinnati Financial Corp.

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We lift our 12-month target price by $7 to $185, valuing CINF shares (currently yielding 2%) at 20x our 2027 operating EPS estimate of $9.15 (raised by $0.10) and at 21.5x our 2026 EPS estimate of $8.60 (raised by $0.10), versus its five-year average forward multiple of 21x and peer average. CINF posted Q1 operating EPS of $2.10 versus a $0.24 operating loss per share a year ago, matching our estimate and topping the $1.94 consensus view, amid 12% higher operating revenues due to 11% premium growth and 14% higher net investment income, with written premium growth of 7% likely at the upper end of peer averages. We believe CINF's competitive strengths include its facile underwriting style and ability to allocate underwriting capital to areas with the most promising fundamentals, positioning it well despite increasingly competitive market conditions. CINF's ability to consistently produce above-peer growth and underwriting profitability will support the shares' premium valuation versus peers, in our view.

$CINF
Research

Research Alert: CFRA Maintains Hold Opinion On Shares Of Linde Plc

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We increase our 12-month target by $48 to $537, using a P/E of 27.1x, equal to LIN's average forward P/E over the last three years. We raise our 2026 EPS estimate by $0.05 to $18.03 and 2027 by $0.26 to $19.81. LIN reported Q1 adj. EPS of $4.33, beating consensus by $0.06, with 30% operating margins and 24% ROC demonstrating the resilience of its business model. Management raised the low end of full-year guidance to $17.60-$17.90 (7%-9% growth), citing confidence despite geopolitical headwinds. The $7.1B project backlog should reach $8B+ by year-end, driven by Electronics projects supporting AI chip manufacturing. Americas volumes grew 2% Y/Y with double-digit hardgoods growth, though EMEA remains challenged by weak industrial activity. Commercial space is emerging as a significant growth driver, with aerospace sales up double-digits. Helium supply tightness presents upside opportunity beyond guidance. We think shares are fully valued at 25.6x our 2027 EPS estimate, limiting upside potential in the near term.

$LIN
Research

Research Alert: CFRA Keeps Buy Opinion On Shares Of Silgan Holdings Inc.

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We lower our 12-month target by $13 to $46, based on an EV/EBITDA of 8.9x our 2026 EBITDA estimate, in line with SLGN's three-year average multiple. We increase our 2026 EPS estimate by $0.05 to $3.90 and raise 2027's by $0.05 to $4.20. Metal containers started the year strong, up 2% Y/Y, with pet food product volume up 11%. Management continues to see a long runway for growth in the fragrance, beauty, and health care category now that it is fully integrated into the Weener portfolio. We anticipate further product launches and customer partnerships in 2027, driving growth in this space. Dispensing and specialty closures headwinds are due to higher-cost inventory with volumes adversely affected by severe weather events in North America. Management also noted that volume is likely to improve in 2H 2026 after securing new business wins that have yet to be commercialized but were secured earlier this year.

$SLGN